FIELD: medicine. SUBSTANCE: method involves determining antiphospholipid antibodies presence in blood serum. The level of IgH and IgG to cardiolipin, phosphatidyl serine and phosphatidyl choline is determined. At least one antibody level being surpassed 1.5-fold or more relative to a reference value, gestosis development is to be diagnosed. EFFECT: improved preclinical diagnosis of the disease.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DETERMINING EFFICIENCY OF IMMUNOCYTOTHERAPY IN PATIENTS WITH OPERABLE TOXEMIA OF PREGNANCY | 1996 |
|
RU2105311C1 |
METHOD FOR INTERRUPTING PREGNANCY AT THE SECOND TRIMESTER IN CASES OF LACK OF AMNIOTIC FLUID | 1995 |
|
RU2124326C1 |
THERAPY METHOD FOR TREATING CHRONIC PLACENTAL INSUFFICIENCY | 1999 |
|
RU2172186C2 |
METHOD FOR DIAGNOSING SEVERE GESTOSIS FORMS | 2003 |
|
RU2259568C2 |
METHOD OF DETERMINING ANTIPHOSPHOLIPID ANTIBODIES | 1995 |
|
RU2128343C1 |
METHOD FOR TREATING AUTOIMMUNE MALE INFERTILITY | 1998 |
|
RU2155596C2 |
ULTRASONIC DIAGNOSIS METHOD FOR DIAGNOSING POSTPARTUM DEFECTS OF RECTUM SPHINCTER | 2002 |
|
RU2226984C2 |
METHOD FOR PREDICTING GESTATION ARTERIAL HYPERTENSION DEVELOPMENT | 1996 |
|
RU2122207C1 |
METHOD FOR PREVENTING INFLAMMATORY COMPLICATIONS AFTER ARTIFICIAL INTERRUPTION OF PREGNANCY IN TRIMESTER I | 2000 |
|
RU2193408C2 |
METHOD FOR PREDICTING REPEATED ARRIVAL OF SEVERE GESTOSIS FORMS | 2003 |
|
RU2239839C1 |
Authors
Dates
1999-08-27—Published
1998-04-21—Filed